Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
boston blog main
boston top stories
4
×
clinical trials
life sciences
4
×
national blog main
new york blog main
alnylam pharmaceuticals
amgen
biotech ipos
boston
cancer
fda
national top stories
new york top stories
novartis
san diego blog main
san diego top stories
the medicines company
abeona therapeutics
accent therapeutics
achilles therapeutics
akouos
alder biopharmaceuticals
alexion pharmaceuticals
alirocumab
alopecia areata
amarin
aridis pharmaceuticals
aristea therapeutics
autoimmune diseases
axitinib
bellus health
bolt biotherapeutics
boulder/denver blog main
boulder/denver top stories
bridgebio
bristol-myers squibb
cell therapy
cidara therapeutics
What
brings
4
×
drug
medicines
new
company
ipo
million
acquire
advantages
agreed
bar
based
begin
billion
bio
biosciences
bio’s
bubbles
cash
cells
cholesterol
class
clinical
codiak
compound
deal
developing
disorders
dyne
dyne’s
exosome
exosomes
expect
fda
formed
fund
gamble
genetic
market
medco
Language
unset
Current search:
brings
×
biotech
×
" boston top stories "
×
" life sciences "
×
@xconomy.com
3 years ago
Codiak Bio’s IPO Brings In $82M as Exosome Clinical Trials Begin
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone